APOA5 rs662799: Understanding Your Genetic Triglyceride Link
The rs662799 variant is a common genetic change located in the promoter region of the APOA5 gene. It is widely studied for its association with elevated serum triglyceride levels and potential impacts on cardiovascular health.
What each genotype means
Typical triglyceride risk profile
This genotype represents the common version of the APOA5 promoter region. Research indicates that individuals with this genotype typically do not carry the specific genetic variation associated with elevated triglyceride levels linked to this site.
This is the most common genotype observed across most global populations.
Increased triglyceride risk
This genotype includes one copy of the C allele, which is a promoter variant often associated with higher plasma triglyceride levels. You may have a statistically higher predisposition to elevated triglycerides compared to those without this variant, which is a known risk factor for coronary heart disease. Please discuss your lipid profile and cardiovascular health with your clinician.
This genotype is found at varying frequencies globally, appearing in a significant portion of the population depending on ancestral background.
Elevated triglyceride risk
This genotype includes two copies of the C allele, which has been consistently associated in research with higher plasma triglyceride levels. Because this variant can influence how your body metabolizes fats, you may have a higher statistical risk for hypertriglyceridemia and related cardiovascular conditions. It is recommended that you discuss your lipid management and heart health strategies with your healthcare provider.
This genotype is less common than the TT or TC genotypes but is present in many populations worldwide.
What is rs662799?
The rs662799 variant is a single nucleotide polymorphism (SNP) located in the promoter region of the APOA5 gene, often referred to in scientific literature as the -1131T>C variant. A promoter region is a segment of DNA that acts as a control switch, determining how much of a specific protein is produced by a gene. In this case, the presence of the C allele instead of the T allele at this specific location can influence the expression of the APOA5 protein. Because this variant sits in a regulatory area, it is considered a functional SNP, meaning it has the potential to alter biological processes rather than just serving as a neutral marker in the genome.
The Role of the APOA5 Gene
The APOA5 gene provides instructions for making a protein called apolipoprotein A-V. This protein is primarily produced in the liver and plays a critical role in regulating triglyceride levels in the blood. Triglycerides are a type of fat (lipid) that the body uses for energy, but having levels that are consistently too high can be a concern for cardiovascular health. Apolipoprotein A-V helps activate lipoprotein lipase, an enzyme that breaks down triglycerides. When the APOA5 gene is functioning optimally, it helps keep triglyceride levels within a healthy range. Variations in this gene, such as rs662799, may interfere with this process, potentially leading to less efficient breakdown of fats in the bloodstream.
Research and Associations
Extensive research, including genome-wide association studies (GWAS), has linked the C allele of rs662799 to higher serum triglyceride levels. Some studies suggest that individuals carrying the C allele may have a reduced ability to lower their triglyceride levels through certain dietary interventions, such as a Mediterranean-style diet, compared to those without the allele. Furthermore, the variant has been investigated for its potential contribution to metabolic syndrome and cardiovascular disease risk. It is important to note that the evidence for these associations is often context-dependent, varying by population and lifestyle factors. While the statistical link to triglyceride levels is well-documented, the clinical impact on an individual's overall health is complex and influenced by many other genetic and environmental factors.
What You Can and Cannot Do
Understanding your genotype for rs662799 provides insight into your genetic predisposition regarding lipid metabolism, but it is not a medical diagnosis. You cannot use this information to predict your exact triglyceride levels or your future risk of heart disease, as these are influenced by diet, exercise, smoking, and other genes. If you are concerned about your lipid profile, the most effective step is to consult with a healthcare provider or a registered dietitian. They can interpret your blood work, assess your overall cardiovascular risk, and provide personalized guidance on lifestyle changes or, if necessary, medical treatments. Never make changes to your health regimen or medication based solely on genetic test results without professional medical advice.
How common is this variant?
The rs662799 variant is common globally, with the minor C allele frequency typically ranging between 0.25 and 0.30 in many populations, though it can vary by ancestry.
Frequently asked questions
Does having the C allele mean I have high triglycerides?
Not necessarily. While the C allele is statistically associated with higher triglyceride levels, many factors like diet, physical activity, and other genes determine your actual blood levels. A blood test is the only way to know your current triglyceride status.
Can I change my risk if I have the C allele?
Genetic variants are fixed, but their impact can often be managed. Lifestyle factors such as maintaining a healthy weight, regular exercise, and a heart-healthy diet are primary ways to manage triglyceride levels regardless of your genotype.
Should I take supplements if I have this variant?
You should never start or change a supplement regimen based on a genetic test. Always discuss your lipid profile and any potential supplements, such as omega-3 fatty acids, with your doctor to ensure they are safe and appropriate for you.
Is this variant the same as a diagnosis of heart disease?
No. This variant is a genetic marker associated with a risk factor (triglycerides), not a disease itself. Having the variant does not mean you have or will develop heart disease.
Sources & further reading
Educational information only, last refreshed 10/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs662799?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29